MYND Life Sciences Inc. Completes $20 Million Sale of Non-Core Business Unit and Unveils Further Strategic Initiatives

MYND Life Sciences Inc. has successfully completed the sale of a non-strategic business unit for $20 million. This strategic move is part of the company’s broader plan to optimize its operations and focus on core areas of growth. Along with this sale, MYND is also implementing additional strategic initiatives aimed at enhancing its overall business strategy and positioning for future success.